Opinion|Videos|March 21, 2025
Managing Adverse Events With Trastuzumab Deruxtecan: Early Detection and ILD Monitoring Strategies
Experts discuss the most common adverse events associated with trastuzumab deruxtecan, how to effectively identify and manage them to minimize treatment interruptions, and how to monitor and address interstitial lung disease (ILD), a known potential adverse effect of trastuzumab deruxtecan.
Advertisement
Episodes in this series
Video content above is prompted by the following:
• What are the most common adverse events associated with trastuzumab deruxtecan, and how can they be effectively identified and managed to minimize treatment interruptions?
• How do you monitor and address ILD, a known potential adverse effect of trastuzumab deruxtecan?
Advertisement
Related to this article
A 3-minute video and quick-reference list of October's 7 FDA cancer approvals, with the biomarker and monitoring points nurses need for each.
Oral vitamin C did not slow clonal growth in the phase 2 EVITA trial but was linked to longer survival.
Kathryn Shady, PhD, RN, OCN, discusses research on emotional dissonance and vicarious trauma among hematology/oncology nurses.
Ellery Palanuk, MSN, RN, CN-BN, explains how navigators rely on multidisciplinary teams and tumor boards as breast cancer treatment evolves.
At EONS 2026, a City of Hope nurse practitioner explains how shifting immunotherapy from infusion to injection can free nurse and chair time.
Oncology nurses play a key role guiding patients about AI breast cancer risk assessment tools, dynamic re-testing, and individualized screening plans.
Dana-Farber nurse practitioners outline ADC patient selection, sequencing, ILD surveillance, and patient education from JADPRO Live 2026.
Dr. Andrew Pecora on leading the first IV oncolytic virus trial, building a top-50 cancer center, and using AI to fix the cost of cancer care.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
October 2026 FDA Approvals: 7 Cancer Updates for Oncology Nurses
2
What Nurses Should Tell Patients About Vitamin C in CCUS and MDS
3
How Oncology Nurses Can Overcome Common Barriers to Research
4
Vicarious Trauma Affects Oncology Nurses in Every Care Setting
5